Mode
Text Size
Log in / Sign up
N/A Completed N=12 Randomized Triple-blind Treatment

Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning

Colorectal Cancer · Fragility · Prehabilitation · Surgery
Source: ClinicalTrials.gov NCT03853473 ↗
Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcomePrimary: 6 Minute Walk Test Distance (Pre Surgery) — 369; 432 Meters

Summary

This project will examine the efficacy of a simple, cost-effective, non-invasive intervention, called remote ischemic preconditioning (RIPC), to reduce frailty in pre-surgical, frail, elderly patients with colon cancer. The investigators hypothesize that RIPC will reduce frailty in the pre-surgical period (as assessed by distance walked during the 6-minute walk test), improve functional capacity 4-weeks postoperatively, and reduce intraoperative blood pressure variability. If successful, future studies will examine the efficacy of RIPC to improve surgical outcomes in frail cancer patients.

Outcome Measures

OutcomeResultp-value
PRIMARY
6 Minute Walk Test Distance (Pre Surgery)
369; 432 —
SECONDARY
10 Meter Walk Test (Pre Surgery)
1.12; 1.27 —
SECONDARY
Timed Up and Go (Pre Surgery)
— —
SECONDARY
Hand Grip Strength (Pre Surgery)
— —
SECONDARY
6 Minute Walk Test Distance (Post Surgery)
— —
SECONDARY
10 Meter Walk Test (Post Surgery)
— —
SECONDARY
Timed Up and Go (Post Surgery)
— —
SECONDARY
Hand Grip Strength (Post Surgery)
— —
SECONDARY
Intraoperative Blood Pressure Variability
— —

Eligibility Criteria

Inclusion Criteria

  • Be between the ages of 55-85
  • Have a positive diagnosis of colon cancer or suspected colon cancer based on pathology report
  • Be scheduled for curative resection of non-metastatic colon cancer
  • Have a 6-Minute Walk Test distance ≤80% of predicted value based on age and sex.

Exclusion Criteria

  • Condition which prevents walking
  • Any condition in which compression of the arm or transient ischemia is contraindicated (e.g. wounds in the arm)
  • Neurodegenerative disorder
  • Unstable angina in previous month
  • Myocardial infarction during previous month.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03853473). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search